Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine

Host response to COVID-19 vaccines is partially evaluated through the estimation of antibody response, specifically the binding anti-spike (anti-S) and the neutralizing antibodies (nAbs) against SARS-CoV-2. Vaccine-induced humoral response affects decisions on the choice of vaccine type, vaccine acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Omran, Eman A., Habashy, Roaa E., Ezz Elarab, Logina A., Hashish, Mona H., El-Barrawy, Mohammed A., Abdelwahab, Ibrahim A., Fekry, Marwa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415602/
https://www.ncbi.nlm.nih.gov/pubmed/36016228
http://dx.doi.org/10.3390/vaccines10081340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415602/
https://www.ncbi.nlm.nih.gov/pubmed/36016228
http://dx.doi.org/10.3390/vaccines10081340

Ejemplares similares